Canopy Growth (CGC): Follow the Acreage CEO

Like the cannabis sector in general, Canopy Growth (CGC) trades near multi-year lows. At the current price of $22.75, the stock isn’t the favorite in the...

Surprising Departure of HEXO’s New CFO Could Indicate Weak Financial Unit

As if there weren't already enough challenges negative catalysts for HEXO (HEXO) to overcome, the recent resignation of its new CFO has generated questions on...

Zenabis Global Stock Is Dirt Cheap, but Financing Risk May Keep It That Way

Zenabis Global (ZBISF) has large global cannabis aspirations, but the company also has a balance sheet that doesn’t match the size of their aspirations. When...

Is Canopy Growth (CGC) Stock Really a Good Contrarian Play?

Canopy Growth (CGC) has been taking a beating after its latest disappointing earnings report, the ouster of popular CEO Bruce Linton, weak allocation of...

3 Cannabis Stocks Poised to Benefit From the CBD Sports Market

The legalization of hemp via the 2018 Farm Bill opened up exciting new markets for cannabis companies. While marijuana remains an illegal at the federal level...

Cannabis Stock Charlotte’s Web Should Benefit From Market Weakness

As the cannabis market takes a hit due to fears over lost vaping revenues and the industry in general is still struggling to generate profits, Charlotte’s...

Finally, There Is a Silver Lining for Canopy Growth (CGC) Investors

Looking for growth outside of its former focus on recreational pot, Canopy Growth (CGC) has acquired a majority stake in BioSteel Sports Nutrition, a leading...

Aurora Cannabis (ACB): Great Assets, Tone-Deaf Management

Analysts identified the biggest risk to the Aurora Cannabis (ACB) story as the company aggressively spending the business towards a liquidity problem. The...

Acreage Holdings Stock Has the Goods for Bulls Looking for a Winner in the U.S. Cannabis Space

Most U.S. cannabis companies are poised to be big winners from the eventual passing of the SAFE Banking Act, including Acreage Holdings (ACRGF). Approval by...

3 Marijuana Stocks That Could Get Hammered from the Vaping Crises

As if the bloodbath concerning cannabis stocks hasn't been bad enough in 2019, the growing crisis surrounding vaping deaths and sicknesses has further...

3 Cannabis Stocks With Sky-High Potential

With the end of 2019 coming up, the climate is changing for the cannabis industry. Canada is getting ready to enact the second stage of its legalization drive,...

Canopy Growth (CGC): The Bears Remain in Control

Canopy Growth (CGC) has been on a downward spiral lately, with part of it being the result of growing negative sentiment in the cannabis industry, and partly...

Pot Stock MedMen Enterprises Should Reward Patient Investors

MedMen Enterprises (MMNFF) recently announced it opened three new retail outlets in Florida, bringing the total number of operating stores in the U.S. to...

Marijuana Stock Harvest Health & Recreation Is a Solid “Buy the Dip” Name

With so much news in the last week impacting the U.S. cannabis sector, the reasons for massive declines on a stock like Harvest Health & Recreation (HRVSF)...

Cresco Labs Secures Non-Dilutive Funding, But Regulatory Issues Remain a Problem

Cresco Labs (CRLBF) announced it has raised $46.3 million in non-dilutive capital in a sale-and-leaseback agreement with Innovative Industrial...

Supreme Cannabis: The Supreme Opportunity Persists

As the market still fails to separate the Canadian cannabis companies from the overhyped one’s trading on major U.S. stock exchanges, Supreme Cannabis...

iAnthus: Building out Markets on the Cheap

The US multi-state operators (MSOs) were already attractively priced stocks, but now they are consolidating the industry on the cheap. A prime example is the...

Organigram Holdings (OGI) Positioned Well for Cannabis Rebound

Organigram Holdings (OGI) is putting its pieces together at the right time. As the sentiment for the cannabis industry has temporarily turned negative, the...

GW Pharmaceuticals (GWPH) Stock Is Dashing Towards a Brighter Future

GW Pharmaceuticals (GWPH) announced on Monday that it had received approval to sell its epilepsy drug in the world's largest market, as measured by GDP. The...

The Bull Case for HEXO Stock Is Strong

As the stock market continues to beat down the Canadian cannabis stocks, investors need to find companies poised to benefit from Cannabis 2.0 with attractive...

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts